AbbVie makes Richter richer, paying $25M to form discovery pact with Vraylar originator

AbbVie makes Richter richer, paying $25M to form discovery pact with Vraylar originator

Source: 
Fierce Biotech
snippet: 

AbbVie has returned to the source of its antipsychotic powerhouse Vraylar in search of another blockbuster, paying $25 million upfront to form a new drug discovery pact with Gedeon Richter.